Abstract
In two controlled trials, involving 75 patients, on the prevention of bleeding from gastric erosions in fulminant hepatic failure, antacids given four-hourly had no significant effect. Only 35% of intragastric pH recordings taken at two-hourly intervals in the treated group were maintained above 5 with the doses used, whereas this could be consistently achieved with the histamine H2-receptor antagonists, metiamide and cimetidine. In the group receiving these drugs only 1 patient out of 26 bled, compared with 13 (54%) of the controls, a highly significant difference. Blood-transfusion requirements were significantly less in those treated with H2-receptor antagonists.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Antacids / therapeutic use*
-
Clinical Trials as Topic
-
Drug Evaluation
-
Esophageal and Gastric Varices / prevention & control
-
Gastrointestinal Hemorrhage / epidemiology
-
Gastrointestinal Hemorrhage / mortality
-
Gastrointestinal Hemorrhage / prevention & control*
-
Guanidines / therapeutic use*
-
Hepatic Encephalopathy / complications*
-
Hepatic Encephalopathy / mortality
-
Histamine H2 Antagonists / therapeutic use*
-
Humans
-
Imidazoles / therapeutic use*
-
Metiamide / therapeutic use
-
Peptic Ulcer Hemorrhage / prevention & control
-
Stomach Ulcer / complications
-
Stomach Ulcer / etiology
Substances
-
Antacids
-
Guanidines
-
Histamine H2 Antagonists
-
Imidazoles
-
Metiamide